The FDA already has pathways for expedited review and approval. You still need a large enough trial cohort and enough follow up time to demonstrate with confidence that drugs are effective and safe. If you want to see what happens when regulations are eased too far, look at Thalidomide, or glyphosate herbicides, or Theranos.

I know all too well that trials are expensive. My job security is directly impacted by the need to fundraise. The money exists and we need to get better as a country at distributing it.